To further illustrate the characteristics of the tumor cells in the microenvironment, we quantified the cells expressing combinations of BTN2A1, PD-L1, and/or PD-L2 in the tile scan of the tumor section from the two-dose treatment (Supplementary 5B). This evidence concerns the gene PDCD1LG2 and neoplasm.